Varicella-zoster virus (VZV), labelled with [35S]methionine or [14C]glucosamine, was purified by centrifugation through sucrose gradients followed by equilibrium centrifugation in CsC1, and analysed by SDS-polyacrylamide gel electrophoresis (SDS-PAGE). At least 32 polypeptides ranging in mol. wt. from approx. 280 × 103 to 21.5 × 103 (280K to 21.5K) and six glycopeptides ranging in mol. wt. from approx, lI5K to 45K (gpl to gp6) were found in the virion. The immunological relationship of VZV and herpes simplex virus (HSV) was investigated. In neutralization (NT) tests, no cross-neutralization was observed between VZV and HSV-1 or -2. In fluorescent antibody staining, however, a cross-reaction was observed between VZV-and HSV-1-infected human embryonic lung (HEL) cells and heterologous antiserum. When cross-reactions were investigated by immunoprecipitation followed by SDS-PAGE, several cross-reacting polypeptides were discovered. Cross-reacting glycopeptides of 64K (gp3) and 55K (gp5) were isolated from VZV-infected cell lysates by affinity column chromatography to immobilized HSV-1 antibodies.
INTRODUCTION
It has been postulated that varicella-zoster virus (VZV) and herpes simplex virus (HSV) are immunologically related, based on the observation that a rise in the titre of antibody to the heterologous virus occurred in infection with the other virus (Weller & Witton, 1958; Kapsenberg, 1964; Ross et al., 1965; Svedmyr, 1965) . It should be noted, however, that Schaap & Huisman (1968) and Schmidt et al. (1969) observed that such a rise in complement fixing, neutralizing or fluorescent antibody occurred only in patients having serological evidence of prior infection with that virus. Therefore, the possibility remains that preexisting antibody was reinforced by infection with another virus. Recently, Harbour & Caunt (1979) reported that VZV and HSV were immunologically related by immunofluorescent staining but no cross-reaction was detected by gel precipitation tests.
In this study, we first characterized purified VZV virion polypeptides by SDS-PAGE and then investigated the immunological relationship between VZV and HSV. No crossneutralization was observed with VZV and HSV. However, using fluorescent antibody staining, cross-reactivity was observed in VZV-and HSV-infected ceils with heterologous antiserum. Using SDS-PAGE and fluorography, several polypeptides were detected in immunoprecipitates of extracts of VZV-or HSV-infected cells with heterologous antiserum.
10% calf serum and maintained in the same media with 3 % calf serum.
Virus. The Kawaguchi or Oka strain of VZV (Takahashi et al., 1975; Iltis et al., 1977; Oakes et al., 1977) was propagated in HEL cells and stocked as cell-free virus in SPGC medium [PBS(-) containing 5% sucrose, 0.1% sodium glutamate and 10% foetal calf serum; Asano & Takahashi, 1978] at --70 °C. HSV-1 (Seibert strain) and HSV-2 (UW268 strain) were also propagated in HEL cells and cell-free virus obtained after rapid freezing and thawing of infected cultures was stored at -70 °C.
Antisera. Antiserum to VZV was prepared as follows. Varicella virus of the Oka strain was passaged in green monkey kidney cells seven times. At the last passage, culture medium containing 3 % monkey serum instead of 3 % calf serum was used after virus infection. When a cytopathic effect appeared, cells were washed three times with phosphate-buffered saline (PBS), scraped off the glass surface by a rubber policeman, and centrifuged. Pelleted cells were sonicated and homogenized with Freund's complete adjuvant, and the homogenate was injected into green monkeys intramuscularly three times at 3-week intervals. Serum was collected 1 week after the last injection. Antibody to HSV-1 and HSV-2 were prepared in rabbits by successive intraperitoneal injection of infected rabbit kidney cells maintained in rabbit serum.
Neutralization (NT) test.
The NT test was performed as described previously (Asano & Takahashi, 1978) . Samples of VZV diluted to contain approx. 100 to 200 p.f.u./0-1 ml were mixed with equal amounts of serial two-or fourfold diluted serum inactivated by heating at 56 °C for 30 min, and the mixtures were incubated at 37 °C for 1 h with occasional shaking. Two-tenth ml vol. of serum-virus mixture were inoculated on to cell cultures in 60 mm plastic dishes, which were incubated at 37 °C for 1 h to permit adsorption of non-neutralized virus. Medium was added and incubation was continued for 7 to 8 days until the plaques were large enough to count. Antibody titres were expressed as the reciprocal of the highest dilution of serum producing 50% or more reduction in the plaque count. Neutralization of HSV-1 or HSV-2 was performed by the same plaque reduction method except that virus was adsorbed for 2 h and plaque numbers were counted on the 4th day. Immunofluorescent studies. HEL cells were grown on coverslips in 60 mm glass plates. The coverslips were infected with VZV or HSV at an input multiplicity of infection of approx. 0.005. After an adsorption period of 1 h at 37 °C, the cultures were washed with PBS and maintenance medium was added. When cytopathic change was detected, coverslips were taken out and washed with PBS, air-dried and fixed in acetone for 5 min at -20 °C. The anti-complement immunofluorescence technique described previously (Yamanishi et al., 1980) was employed for staining. For the test with anti-VZV serum, a mixture containing equal proportions of human infant complement diluted 1 : I0 and anti-VZV serum diluted 1:10 was mounted on coverslips. For the test with anti-HSV-1 or anti-HSV-2 serum, similar mixture of complement and anti-HSV-1 or anti-HSV-2 serum diluted 1:10 was used. After incubation at 37 °C for 30 min, the coverslips were washed thoroughly with PBS and incubated with fluorescein isothiocyanate-conjugated anti-human C3 goat serum diluted 1:20 (Hyland Laboratories, Los Angeles, Ca., U.S.A.). After a secondary incubation at 37 °C for 30 min, the coverslips were washed with PBS, mounted in a 1:9 solution of PBS and glycerine, and viewed with an Olympus fluorescence microscope. Purification of VZV and fractionation of virions. Labelled virus-infected cells were washed twice with PBS and scraped with a rubber policeman, and suspended in SPGC medium. The cell suspension was sonicated with an ultrasonic disruptor (Tomy, 200 W) for 1 min in an ice-bath and centrifuged at 2000 g for 20 min at 4 °C. The supernatant was layered on to 10 to 50% (w/v) linear sucrose gradients containing 10 m~i-tris pH 7.8, 1 mM-EDTA, and centrifuged at 27000 rev/min for 1 h at 4 °C in an SW27 rotor (Beckman). Fractions were collected from the bottom and aliquots were counted to determine the radioactivity. Peak fractions were collected and their density adjusted to 1.265 g/ml with CsC1 at 25 °C and centrifuged at 33 000 rev/min for 40 h at 4 °C in an SW41 rotor (Beckman). A single band was visible near the bottom of the tube, which was aspirated with a syringe. This visible band contained enveloped virions by electron microscopy. The enveloped virion fraction was suspended in TE solution (10 mM-tris pH 7.8 containing 1 mM-EDTA) and concentrated by centrifugation at 30000 rev/min for 2 h at 4 °C in an SW41 rotor (Beckman). The pellet was divided into two parts. One part was used as enveloped virion fraction; the other part was treated with 0.5 % Nonidet P40 (NP40) in TE solution. It was then centrifuged at 30000 rev/min for 2 h at 4 °C in an SW41 rotor and the pellet was used as nucleocapsid fraction. The supernatant, after addition of rabbit serum as a carrier protein, was precipitated with 10% trichloroacetic acid (TCA) in an ice-bath for 1 h, and the precipitate was washed with acetone and used as the envelope fraction. Each fraction was suspended in the sample buffer (1% SDS, 3% 2-mercaptoethanol, 10% glycerol, 0.001% phenol red, and 50 mM-tris-HCl pH 8.2) and solubilized by heating at 100 °C for 3 rain.
Immunopreeipitation. Infected cells labelled with [35S]methionine or [14C]glucosamine were
solubilized in 4 ml TD buffer (1% Triton X-100, 0.5 % sodium deoxycholate, 0-15 M-NaC1, 1 mM-phenylmethylsulphonyl fluoride, 10 raM-sodium phosphate buffer pH 7.2) per 100 mm dish, and then sonicated for 3 min in an ice-bath. The preparations were allowed to stand for 1 h on ice, and then centrifuged for 2 h at 30000 rev/min (Hitachi RPS 40T rotor) at 4 °C. The resulting supernatant (TD lysate) was used for immunoprecipitation. Before immunoprecipitation, the antiserum was absorbed with uninfected HEL cell lysate. Immunoprecipitation was done following the method of Kessler (1975) . The TD lysate of labelled infected cells was mixed with antiserum and incubated with a suspension of Staphylococcus aureus (Cowan I strain). The mixture was centrifuged at 5000 rev/min for 6 rain and the immunoprecipitate was washed three times with TD buffer and once with 10 mM-sodium phosphate buffer pH 7-2. The immune complex was separated from the bacterial adsorbent by heating the resulting pellet in 'sample buffer' for SDS-PAGE for 3 min at 100 °C, and the mixture was centrifuged at 5000 rev/min for 10 rain. The supernatant was subjected to SDS-PAGE.
SDS-PAGE.
Polyacrylamide gel electrophoresis in tris-glycine-buffered (pH 8.1) SDS-slab gel (4% stacking, 7-5 to 15 % continuous gradient or 10% gel) was carried out at a constant voltage of 150 V for 6 h. After electrophoresis, the gel was stained with Coomassie Brilliant Blue R-250 and destained. Fluorography was carried out after treating the gels with 2,5-diphenyloxazole in dimethyl sulphoxide by the method of Bonner & Laskey (1974) .
Preparation of affinity column coupled to anti-HSV-1 serum. The 7S fraction of the anti-HSV-1 rabbit serum was obtained by precipitation with half-saturated ammonium sulphate followed by Sephadex G-200 column chromatography. Cyanogen bromide activation of Sepharose 4B was based on the procedures of Ax6n et al. (1967) . Briefly, 10 g Sepharose 4B was mixed with 10 ml distilled water and 1 g cyanogen bromide dissolved in 2 ml N,N-dimethylformamide. The pH was immediately adjusted and maintained at 11 with 5 M-NaOH in an ice-bath. When the reaction had ended (about 8 rain), the Sepharose was washed with cold water and then washed with 0.1 M-C-BCB (carbonate-bicarbonate buffer pH 9) on a Buchner funnel under suction. The activated Sepharose was suspended in 7 ml antibody solution in BBS (30 mM-borate-buffered saline) and the suspension was gently mixed in the cold room overnight. Conjugated Sepharose was packed in a small column (10 ml disposable plastic syringe) and washed once with 0.05 M-monoethanolamine in 10 mM-borate buffer pH 8-5, and finally washed with BBS. Antigen solution used for affinity column chromatography. VZV-infected cells were solubilized by TD buffer and the cell lysate was centrifuged at 19 000 rev/min for 2 h at 4 °C. The supernatant was used as an antigen solution for affinity column chromatography immobilized on HSV-1 antibody.
Elution. Virus antigen solution was applied to affinity column and washed alternately with 100 ml BBS, 100 ml 0.2 M-glycine-HC1 pH 2.9 and 100 ml BBS, and finally eluted by 3 M-potassium thiocyanate in BBS. The eluted antigen was concentrated by TCA precipitation and applied to SDS-PAGE. After electrophoresis, the gel was stained with Coomassie Brilliant Blue R-250 and dried. The highly sensitive silver stain method was also used for staining (Merril et al., 1979) .
Estimation ofmol, wt. ofpolypeptide. The mol. wt. of the peptides and glycopeptides were estimated by comparison with marker proteins in the same gels. The markers used, with mol. wt. in parentheses, were thyroglobulin (330 000), ferritin (220 000 and 18 500), phosphorylase b (94000), bovine serum albumin (67000), catalase (60000), ovalbumin (43000), lactate dehydrogenase (36000), carbonic anhydrase (30000), trypsin inhibitor (20100), alactalbumin (14400) (all from Pharmacia) and RNA polymerase (155000 and 165000) (Boehringer, Mannheim).
RESULTS

Purification of VZ V and determination of its constituent polypeptides
VZV identified by electron microscopy was purified as described in Methods. The enveloped virion fraction was found at the density of 1.272 g/ml of CsC1 solution.
To examine the degree of purification, an artificial mixture of VZV-infected cells labelled with [3H]thymidine and uninfected cells labelled with [35S]methionine was subjected to the purification procedure. The ratio of the two radiolabels was determined at each step, which represented the degree of purification. Infected cells labelled with [3H]thymidine were used to identify the virion fraction and uninfected cells highly labelled with [35S]methionine were used to estimate the degree of contamination by cellular component of the virion fraction. As shown in Table 1 , the sucrose density gradient procedure produced a 20-fold purification and the CsC1 centrifugation gave a further fourfold purification. The virion fraction was separated from membrane vesicles by equilibrium centrifugation in CsC1. Thus, cellular components in the virion fraction constituted 0.06% of the original cytoplasmic fraction. Further centrifugation in CsCI yielded no apparent improvement in purity. (data not shown). Therefore, there should be little or no contamination by cellular polypeptide of the band of purified virion fraction. In the purified virion fraction, at least 32 3sS-labelled polypeptide bands and six [14C]glucosamine-labelled bands were detected (Fig. 1, Table 2 ). In the 3~S-labelled envelope fraction, four polypeptide bands (l15K, 80K, 64K and 55K) corresponding in mol. wt. to four of the six [14C]glucosamine-labelled bands were (apparently) detected ( Fig. 1 b, lane 6) . Polypeptides with mol. wt. of 155K (VP4) and 45K (VP22) that were prominently observed in whole virions were not detected in the nucleocapsid fraction, yet were undetectable in the envelope fraction. It is conceivable that those polypeptides had been in the envelope, were solubilized by NP40 treatment but were lost on washing with acetone.
[14C]glucosamine-labelled polypeptides were not clearly observed in the envelope fraction ( Fig. 1 a, lane 3) . This might be due to some loss of glycopeptides in the isolation procedure of envelope fraction. A similar phenomenon was observed in the migration patterns of [35S]methionine-labelled virus envelope ( Fig. 1 b , lanes 4 and 6).
Cross-neutralization test with VZV and HS V-1 or HS V-2
Anti-HSV-1 or -2 rabbit sera ha+eing an NT antibody titre of 640 to 2560 against homologous virus were proved to have no detectable antibody titre to VZV even when guinea-pig complement was added to the antigen-antibody mixture. Anti-VZV monkey or guinea-pig sera having an NT antibody titre of 640 to 1280 to VZV were likewise found to have no detectable antibody to HSV-1 or HSV-2 (Table 3) .
Cross-reactivity of immune sera to VZV and HSV-I with heterologous viruses in fluorescent antibody staining
In fluorescent antibody staining using the indirect method with complement, granular fluorescence was observed in nuclei of VZV-infected cells stained with anti-HSV-1 serum while fluorescence was observed throughout the cells stained with homologous anti-VZV serum. HSV-l-infected cells were stained brilliantly in nuclei, faintly in cytoplasm with anti-HSV-1 or -2 sera, and stained in nuclei with anti-VZV serum (Fig. 2) . No specific fluorescence was observed in uninfected cells or with preimmune sera.
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Cross-reacting polypeptides of VZ V and HS V
Cross-reacting polypeptides of VZV and HSV examined by immunoprecipitation and SDS-PAGE
An extract of VZV-infected HEL cells was immunoprecipitated with anti-HSV-1 or -2 sera and the immunoprecipitate was analysed by SDS-PAGE and fluorography. A main band of 64K (gp3) glycopeptide and minor bands of 115K (gpl) and 55K (gpS) glycopeptides were detected (Fig. 3, 4) . The densities of these bands were not always constant, and minor bands were occasionally difficult to detect in repeated experiments. This is probably due to non-uniform labelling conditions of VZV-infected cells. As it was difficult to get high-titred VZ cell-free virus, a low input multiplicity of cell-free virus or infected cells was used as inoculum, which might have caused variation in the labelling conditions. When a lysate of labelled HSV-1-or HSV-2-infected HEL cells was immunoprecipitated with anti-VZV serum and examined by the same procedure, main bands of 115K to 120K possibly corresponding to gAgB (Spear, 1976 ) and a minor band of 53K to 55K glycopeptides possibly corresponding to gD or pgD (Eisenberg et al., 1979) were usually detected (Fig. 4) and a minor band of 130K polypeptide was occasionally detected (Fig. 5) . With preimmune sera, the results were uniformly negative (data not shown).
Isolation of cross-reactive VZV polypeptides by affinity column coupled to antibody to HSV-1
A soluble extract of VZV-infected cells was applied to the affinity column coupled with anti-HSV-1 serum. Polypeptides of 64K and 55K were isolated, as determined by Anti-VZV serum * The effect of addition of guinea-pig complement was examined. Equal amounts of antigen, antiserum and guinea-pig complement (fresh guinea pig serum diluted 1 : 10) were mixed and incubated at 37 °C for 1 h, and aliquots of the mixtures were inoculated on to cell cultures. S D S -P A G E (Fig. 6 ). The two polypeptides eluted correspond in mol. wt. to the major cross-reactive glycopeptide (gp3) and minor cross-reactive glycopeptide (gp5) in VZVinfected cells immunoprecipitated with HSV antiserum shown in Fig. 4 . The other minor cross-reactive glycopeptide (gpl) was not detected in the eluted solution. It is not clear whether that polypeptide was present in too small an amount to be detected or was too strongly bound to the column. Cross-reacting polypeptides of VZ V and HS V 
Cross-neutralization tests between VZ V and HS V-l or HS V-2
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D I S C U S S I O N
We have attempted to purify VZV virions and to characterize the polypeptide of the virion. Recently, Shemer et al. (1981) have reported that VZV virions could be isolated from infected cells by centrifugation of the virus on a glycerol velocity gradient followed by glyceroltartrate equilibrium gradient centrifugation, and that VZV was found to be composed of at least 33 species of polypeptide ranging in mol. wt. from 244000 to 16000 and five glycopeptides ranging in mol. wt. from 140 000 to 52 000. We used sucrose density gradient centrifugation followed by equilibrium centrifugation in CsC1, which was effective in the elimination of nucleocapsids and contaminating cell components from the virion fraction.
Analysis of the polypeptide composition of VZV by SDS-PAGE revealed that the VZ virion contains at least 32 polypeptides ranging in mol. wt. from approx. 280K to 21.5K including six glycopeptides ranging in mol. wt. from approx. 115K to 45K. As glycosylation occurs heterogeneously, it is usually not easy to determine the number and mol. wt. of glycopeptide bands precisely. It was particularly difficult to analyse the VZV glycopeptides because of the experimental problems with virus infection described previously. Thus, the number and mot. wt. of glycopeptides of VZV reported by several investigators are not consistent (Asano & Takahashi, 1979 , 1980 Grose, 1980; Shemer et al., 1981; Zweerink & Neff, 1981; Grose et al., 1981) . In the present experiment, we have analysed labelled polypeptides and glycopeptides of virion, nucleocapsid and envelope fractions simultaneously by the same procedures. This was helpful in determining the number and mol. wt. of glycoproteins.
The major polypeptide of VZV nucleocapsid had a mol. wt. of approx. 145 000. Asano & Takahashi (1980) previously reported a polypeptide of mol. wt. 145 000 which appeared to be the main capsid protein. Consistent with this, herpesviruses [HSV-1, HSV-2, Epstein-Barr virus, human cytomegalovirus and pseudorabies virus (PRV)] have been reported to contain a major polypeptide of high mol. wt. (140 000 to 160 000) (Killington et al., 1977) .
The immunological relationship between VZV and HSV has thus far not been entirely clear. Many workers observed a concomitant rise in the antibody titre in NT and CF tests after infection with HSV or VZV to the other virus, but such rises occurred only in those with serological evidence of prior infection with that virus. Some immunological relationship between VZV and HSV, mainly in the immunofluorescence test, was reported by Harbour & Caunt (1979) . In the present study, we used hyperimmune green monkey or guinea-pig sera to VZV. With these sera and anti-HSV serum prepared in rabbit, serological tests of neutralization and fluorescent antibody staining were done with heterologous viruses. No apparent cross-neutralization was detected between VZV and HSV-1 or HSV-2, but cross-fluorescent antibody staining was observed mainly in nuclei of VZV-and HSV-1-infected cells with heterologous antiserum. In either HSV-or VZV-infected cells, immature virus particles first appear in nucleus as capsids, which become morphologically complete virions after they derive an envelope from the inner nuclear membrane or extension from it (Cook & Stevens, 1970; Roizman & Furlong, 1974; Gershon et al., 1973) . This suggests that virus glycopeptides are abundant in the region of nuclear membrane of infected cells, which would be incorporated into the envelope of virus particles. Our present study revealed that several cross-reacting glycopeptides between HSV and VZV exist in the virus envelope. Therefore, it may be reasonable to presume that virus glycopeptides in or near the nuclear membrane or virus particles in the perinuclear region were predominantly stained at some stage of infection with heterologous sera containing antibodies to cross-reacting virus glycopeptides. Temporal sequential studies with monoclonal antibody will be needed for the localization of cross-reacting proteins in detail in infected cells.
SDS-PAGE of the immunoprecipitate of radiolabelled lysate of VZV-infected cells with anti-HSV serum showed a main band of 64K (gp3) and minor bands of 115K (gpl) and 55K (gp5) glycopeptides. In similar analysis of the immunoprecipitate of HSV-1-or HSV-2-infected cell lysate with anti-VZV serum, a main band of 115K to 120K and minor band of 53K to 55K glycopeptides were detected. These might correspond to gAgB and gD or pgD of HSV-1 and HSV-2 (Spear, 1976; Eisenberg et al., 1979) .
Since it has been reported that B virus is immunologically related to HSV-1 and HSV-2, the possibility should be considered that antibody to preexisting B virus was induced in green monkeys by immunization with VZV in the present study. However, this is unlikely because antiserum to VZV prepared in guinea-pigs which should be free from B virus also gave a similar pattern of immunoprecipitated polypeptides to that given by antiserum prepared in green monkeys (representatively shown in Fig. 5 ). Furthermore, antisera to VZV prepared in the present study had no detectable antibody to HSV (Table 3) . It was reported that anti-B virus serum neutralizes HSV as well as B virus (Watson et al., 1967) . Therefore, it is highly unlikely that the results reported here were due to B virus reactivity. Norrild et al. (1978) have reported that they found one common antigen in antigens from four herpesviruses (HSV-1, HSV-2, bovine herpes virus and B virus) by immunoelectrophoretic analyses and that a glycopeptide with a mol. wt. of 125000 carried the common antigenic determinants. Yeo et al. (1981) reported on studies of cross-reacting antigens of five herpesviruses, HSV-I, HSV-2, bovine mammillitis virus (BMV), PRV and equine abortion virus (EAV). Antiserum to HSV-1 or HSV-2 precipitated the major capsid polypeptides more efficiently from extracts of cells infected with BMV than from extracts of those infected with PRV or EAV, the predominant polypeptide in all the heterologous precipitates corresponding to the major DNA-binding protein. We are at present uncertain whether DNA-binding proteins of VZV carry the common antigenic determinants with other herpesviruses. Studies on the isolation of glycoproteins and DNA-binding proteins of VZV are under way. Monospecific antibodies to those proteins would be helpful to clarify their immunological properties particularly with regard to common antigenic determinants with corresponding components of other herpesviruses.
